Polarityte Stock Fundamentals
| PTEDelisted Stock | USD 0.07 0.01 10.29% |
Polarityte fundamentals help investors to digest information that contributes to Polarityte's financial success or failures. It also enables traders to predict the movement of Polarityte Stock. The fundamental analysis module provides a way to measure Polarityte's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Polarityte stock.
Polarityte |
Polarityte Company Return On Equity Analysis
Polarityte's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Polarityte Return On Equity | -0.55 |
Most of Polarityte's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Polarityte is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Polarityte has a Return On Equity of -0.5497. This is 97.71% lower than that of the Biotechnology sector and 98.49% lower than that of the Health Care industry. The return on equity for all United States stocks is 77.32% higher than that of the company.
Polarityte Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Polarityte's current stock value. Our valuation model uses many indicators to compare Polarityte value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Polarityte competition to find correlations between indicators driving Polarityte's intrinsic value. More Info.Polarityte is regarded third in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Polarityte by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Polarityte Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Polarityte's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Polarityte could also be used in its relative valuation, which is a method of valuing Polarityte by comparing valuation metrics of similar companies.Polarityte is currently under evaluation in return on equity category among its peers.
Polarityte Fundamentals
| Return On Equity | -0.55 | |||
| Return On Asset | -0.57 | |||
| Operating Margin | (298.68) % | |||
| Current Valuation | (1.7 M) | |||
| Shares Outstanding | 7.38 M | |||
| Shares Owned By Insiders | 3.42 % | |||
| Shares Owned By Institutions | 9.38 % | |||
| Number Of Shares Shorted | 120.43 K | |||
| Price To Book | 0.29 X | |||
| Price To Sales | 2.78 X | |||
| Revenue | 814 K | |||
| Gross Profit | 198 K | |||
| EBITDA | (24.29 M) | |||
| Net Income | (7.83 M) | |||
| Cash And Equivalents | 20.88 M | |||
| Cash Per Share | 3.78 X | |||
| Total Debt | 3.36 M | |||
| Debt To Equity | 0.09 % | |||
| Current Ratio | 6.52 X | |||
| Book Value Per Share | 1.74 X | |||
| Cash Flow From Operations | (22.6 M) | |||
| Short Ratio | 3.19 X | |||
| Earnings Per Share | (0.58) X | |||
| Price To Earnings To Growth | (0.07) X | |||
| Target Price | 0.8 | |||
| Number Of Employees | 42 | |||
| Beta | 1.15 | |||
| Market Capitalization | 1.78 M | |||
| Total Asset | 22.85 M | |||
| Retained Earnings | (516.23 M) | |||
| Working Capital | 11.19 M | |||
| Z Score | -34.2 | |||
| Net Asset | 22.85 M |
About Polarityte Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Polarityte's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Polarityte using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Polarityte based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.PolarityTE, Inc., a clinical stage biotechnology company, develops and commercializes a range of regenerative tissue products and biomaterials for the fields of medicine, biomedical engineering, and material sciences in the United States. The company also develops SkinTE Cryo allows multiple deployments from one original harvest through a cryopreservation process SkinTE point-of-care device to permit the processing and deployment of SkinTE immediately following the initial harvest at the point-of-car PTE 11000, an allogenic, biologically active dressing for use in wound care and aesthetics to accelerate healing of skin and other tissue regeneration products. Polarityte operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 59 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Consideration for investing in Polarityte Stock
If you are still planning to invest in Polarityte check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polarityte's history and understand the potential risks before investing.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |